The board says it will reclassify its proposed final dividend announced for FY19, as an interim dividend following a delay in payout due to Covid-19. Shareholders can expect to receive a payout of 1 cent a share on Jun 8, the company said in a regulatory filing on May 11.
SINGAPORE (May 15): Net profit of catalist-listed pharmaceutical distributor Hyphens Pharma soared 48.6% to $2.1 million in 1Q20 ended March, from the $1.4 million logged a year ago.
On a fully diluted basis, this translates to earnings per share (EPS) of 71 cents, from 48 cents before. At this level, Hyphens Pharma’s net asset value was 15.26 cents a share, against 14.67 cents as at Dec 31.
